Open access
Jul 2026
Safety monitoring of bivalent, quadrivalent, and 9-valent human papillomavirus vaccination in Japan: The vaccine effectiveness, networking, and universal safety (VENUS) study
Assessment of the risk of adverse events of special interest following HPV vaccination among females aged 12–26 using medical claims data linked to routine or catch-up vaccination records provided by municipalities found no statistically significant increased risk.
C. Ishiguro, Hiroya Morita, W. Mimura et al.
· Human Vaccines & Immunothera... · 0 citations